Please enable Javascript to use all features and improve your user experience.
DZIF 2023
Programme
Posters
People
Search
EN
All people
Prof. Dr. Stephan Becker
Marburg/ DE
University Marburg
Sort by Type
Date
Further involvements
25/09/2023
14:50
–
15:00
8 Min.
2 Min.
Short Talk
S-2-3
MVA-MERS-S vaccine candidate elicits long-lasting memory B cell response and highly potent cross-neutralizing antibodies against zoonotic merbecoviruses
Immune Prevention and Therapy
25/09/2023
Poster
P-1-38
A combination of direct acting and host-directed antivirals dramatically suppresses SARS-CoV-2 and MERS-CoV replication
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
25/09/2023
Poster
P-1-39
Brain specific immune responses to Nipah- and Ebola virus infection in
in-vitro
and
ex-vivo
models
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
25/09/2023
Poster
P-1-40
Establishment and characterization of lethal and non-lethal animal models for Marburg virus
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
26/09/2023
Poster
P-2-55
Generation and
in vitro
characterization of two recombinant MVA candidate vaccines expressing Marburg virus glycoprotein or nucleoprotein
Tropical and Emerging Infections
26/09/2023
Poster
P-2-62
Corallopyronin A: successful non-GLP
in vivo
toxicity tests in rat and dog support continued development to first in human trials
Tropical and Emerging Infections
26/09/2023
Poster
P-2-66
Establishment and characterization of two Crimean-Congo hemorrhagic fever virus animal models in mice
Tropical and Emerging Infections
26/09/2023
Poster
P-2-88
The Antiviral Compound Testing Platform (ACTP) and its application to identify broad-spectrum antivirals
Tropical and Emerging Infections
26/09/2023
Poster
P-2-98
Development of a physiologically based biopharmaceutics model for CorA and prediction of human pharmacokinetics and effective dose using enhanced formulation
Tropical and Emerging Infections
26/09/2023
Poster
P-2-101
Diagnostic qRT-PCR as screening assays of antiviral compounds against highly pathogenic RNA viruses
Tropical and Emerging Infections
26/09/2023
Poster
P-2-105
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike induce differential S1- and S2-specific immune responses in humans
Tropical and Emerging Infections
26/09/2023
Poster
P-1-78
Dissecting humoral immune responses to the MVA-MERS-S vaccine candidate using a systems serology approach
Immune Prevention and Therapy
26/09/2023
15:30
–
15:40
8 Min.
2 Min.
Short Talk
S-6-4
The vaccine candidate MVA-MERS-S against Middle East Respiratory Syndrome Coronavirus: safety and immunogenicity results from a randomized-controlled Phase Ib trial
Tropical and Emerging Infections
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy